Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Wai Chun Bio-Technology Ltd. ( (HK:0660) ) has issued an announcement.
Wai Chun Bio-Technology Limited has announced a connected transaction involving the issuance of new convertible bonds valued at HK$15,000,000 to Mr. Lam Ching Kui, a major shareholder and connected person of the company. This transaction, subject to shareholder approval and capital reorganization, aims to offset existing loans and could significantly increase the company’s share capital, impacting its market positioning and shareholder structure.
More about Wai Chun Bio-Technology Ltd.
Wai Chun Bio-Technology Limited is a company incorporated in the Cayman Islands, operating within the biotechnology industry. The company focuses on developing and providing biotechnology products and services, with a market presence in Hong Kong.
YTD Price Performance: 9.09%
Average Trading Volume: 180,809
Technical Sentiment Signal: Buy
Current Market Cap: HK$12.85M
Learn more about 0660 stock on TipRanks’ Stock Analysis page.